0001140361-16-080344.txt : 20160920 0001140361-16-080344.hdr.sgml : 20160920 20160920181220 ACCESSION NUMBER: 0001140361-16-080344 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160916 FILED AS OF DATE: 20160920 DATE AS OF CHANGE: 20160920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNERGY PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001347613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330505269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 2012 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-297-0010 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 2012 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: Synergy Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20080812 FORMER COMPANY: FORMER CONFORMED NAME: PAWFECT FOODS INC DATE OF NAME CHANGE: 20051221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAULSON & CO. INC. CENTRAL INDEX KEY: 0001035674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35268 FILM NUMBER: 161894634 BUSINESS ADDRESS: STREET 1: 1251 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-956-2221 MAIL ADDRESS: STREET 1: 1251 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10020 FORMER NAME: FORMER CONFORMED NAME: PAULSON & CO INC DATE OF NAME CHANGE: 19970313 4 1 doc1.xml FORM 4 X0306 4 2016-09-16 0 0001347613 SYNERGY PHARMACEUTICALS, INC. SGYP 0001035674 PAULSON & CO. INC. 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020 0 0 1 0 Common stock, par value of $.0001 2016-09-16 4 S 0 1973713 5.6113 D 25782955 I By Managed Funds and Accounts Common stock, par value of $.0001 2016-09-19 4 S 0 1500000.00 5.6100 D 24282955.00 I By Managed Funds and Accounts Paulson & Co. Inc. ("Paulson") is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds") and certain separately managed accounts (the "Separately Managed Accounts"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds or held in the Separately Managed Accounts. Each of Paulson and John Paulson may be deemed to indirectly beneficially own the securities directly owned by the Funds or held in the Separately Managed Accounts. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4. /s/ Stuart L. Merzer, General Counsel & Chief Compliance Officer 2016-09-20